Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

DBS: Cognizant Technology Solutions Corp – Hold Target Price USD71

Posted on November 6, 2023November 6, 2023 By alanyeo No Comments on DBS: Cognizant Technology Solutions Corp – Hold Target Price USD71
3Q23 results above street estimates
  • 3Q23 adjusted net income of US$586m (+5.0% q-o-q, -3.2% y-o-y) was 7% above street estimates due to margin surprise.
  • Revenue of US$4,897m (+0.2% q-o-q, +0.8% y-o-y) in 3Q23, was inline with street estimates, revenue growth was led by all geographies and verticals except for Health sciences sector.
  • 4Q23F revenue guidance of US$4,690m-US$4,820m (-3.1% to -0.4% y-o-y) is inline with street estimates of US$4,800m

3Q23 adjusted net income of US$586m (+5.0% q-o-q, -3.2% y-o-y) was 7% above street estimates due to margin surprise. Cognizant Technology Solutions Corp (CTSH) reported Adjusted net income of US$586m (+5.0% q-o-q, -3.2% y-o-y) in 3Q23 excluding the one off restructuring charges related to Next Gen program. Net income was 6.7% above street estimates due to margin surprise driven by lower-than-expected SG&A expenses arising from savings from CTSH’s Next Gen program. SG&A expenses in 3Q23 stood at US$801m (-3.5% q-o-q, -4.4% y-o-y). CTSH reported Adjusted operating income of US$758m (+9.2%, -5.0% y-o-y) in 3Q23, 7.5% above street. Adjusted operating margin improved to 15.5% in 3Q23 compared to 14.2% in 2Q23. CTSH reported revenue of US$4,897m (+0.2% q-o-q, +0.8% y-o-y) in 3Q23, inline with street estimates and the guidance. Sequential revenue growth was led by all geographies and verticals except for Health sciences sector which dropped -2.4% q-o-q (flat y-o-y) on softer discretionary spending among some clients. CTSH ended 3Q23 with a trailing 12-month (TTM) bookings of US$26.9bn, up 16% y-o-y and a strong book-to-bill ratio of 1.4x (unchanged q-o-q). In 3Q23, 30% of the bookings were large deals, of which three of them exceeded US$100m each. 

4Q23F revenue guidance of US$4,690m-US$4,820m (-3.1% to -0.4% y-o-y) is inline with street estimates of US$4,800m. CTSH highlighted that the 4Q23F revenue guidance range has widened compared to historical quarterly guidance, reflecting a heightened level of uncertainty regarding client discretionary spending and recent pace of decision-making heading into FY23F. Adjusted operating margin guidance for 4Q23F is ~14.5% (15.5% in 3Q23 and 14.2% in 4Q22) inline with streets estimates of 14.4%. 4Q23F adjusted operating income margin is lower than 3Q23, due to seasonality.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:Cognizant Technology Solutions Corp

Post navigation

Previous Post: DBS: Mondelez International Inc – Buy Target Price USD78
Next Post: DBS: Kraft Heinz – Hold Target Price USD35

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme